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Abstract: Objective: To investigate the effect of a short-term, robotic-assisted (exoskeleton) gait
training (RGT) program on central and peripheral hemodynamic measures in patients
with spinal cord injury (SCI).
Design: Parallel group, non-randomized trial with before (baseline) and after (follow-up)
assessments.
Setting: Single-center, community-based neuro-physiotherapy practice.
Participants: Twelve individuals with SCI (ASI A to C).
Interventions: Participants completed either a 5-day RGT program plus physiotherapy
(n=6), or a usual care physiotherapy only program (control group; n=6). The RGT
program consisted of daily 60-minute physiotherapy and 90-minutes of RGT. Outcome
measures were measured before and after the rehabilitation program.
Main Outcome Measure(s): The primary outcome measure was arterial wave reflection
(Augmentation index [AIx]), with central and peripheral blood pressures also reported.
Data is presented as mean (SD) and effect sizes (partial eta squared; η2p).
Results: There was a significant reduction in AIx (30±18 to 21±15 %; η2p=0.75) and
mean arterial pressure (89±11 to 82±10 mmHg; η2p=0.47) following completion of the
RGT program (both P<0.05). There were no changes in these measures for the control
group. Although not significantly different, medium to large effects were observed in
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
favor of RGT for all other central and peripheral measures (η2p=0.06 to 0.21), except
for heart rate and pulse pressure (η2p<0.04).
Conclusions: RGT using an exoskeleton is a promising therapy for improving
cardiovascular health in patients with SCI. Specifically, this study indicates decreased
arterial wave reflection, and supports the need for larger randomized controlled trials.
Trial Registration: Clinical trials Registry (https://clinicaltrials.gov/; NCT03611803).
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Dear Sir or Madam, 
I am re-submitting a manuscript for the Journal of Spinal Cord Medicine (Ref.:  Ms. No. 
JSCM-D-19-00062). The study is entitled “Effects of robotic-assisted gait training on the 
central vascular health of individuals with spinal cord injury: A pilot study”.  
 
We have amended the manuscript in accordance with the recommendations from the Editorial 
team and reviewers. We look forward to receiving further feedback from the Journal.  
 
 Yours sincerely, 
 
Dr James Faulkner 
Department of Sport, Exercise and Health, University of Winchester, Winchester, SO22 4NR, 
UK. Email: James.Faulkner@winchester.ac.uk; Tel: +44 (0)1962 624932 
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Ref.:  Ms. No. JSCM-D-19-00062 
EFFECT OF ROBOTIC-ASSISTED GAIT TRAINING ON THE VASCULAR HEALTH OF INDIVIDUALS WITH SPINAL CORD 
INJURY 
The Journal of Spinal Cord Medicine 
 
Dear Dr. Faulkner, 
 
Your manuscript has undergone our peer review process.  It will be recommended for publication in the 
Journal, pending major revision as suggested by the reviewers.  Please review their comments below.  
Thank you for your positive response to the manuscript. We have amended the manuscript in line with the 
Editor and reviewer comments.  
 
Note that we require a minimum of three files for the revision: a response to reviewer file, one blinded 
manuscript file showing tracked changes and one blinded manuscript file with all changes accepted.  Please 
ensure that the references are cited in Vancouver style in the text,  
This has been checked and will be submitted as requested. 
 
Language and language-editing:  
If the referees' comments have raised concerns over the use of English in your paper, it is important that you 
check and revise your paper carefully, preferably with the assistance of a native English speaker, to ensure the 




Comments from the Editors and Reviewers: 
 
Editorial Office Comments: 
* Please have the following authors respond to the author verification email (Note: Do not include this item in 
Response to Reviewers due to blinding of document) - XXX, XXX, and XXX. Ask authors to check spam/junk mail 
folder. Please note that verification links do not work as well with cell phones. It is best to use a computer 
when verifying authorship. 
I have been informed by these co-authors that they have now completed the verification process. 
 
* Please put a copy of your Conflict of Interest statement with your Funding Statement in your manuscript file 
above the References section. 
Amended as requested 
 
* Please include the title of your manuscript in the manuscript files. 
Amended as requested. 
 
* In title of the manuscript, only capitalize the initial word, proper nouns, and the first word after a colon. 
Please make sure that the title on your title page, manuscript file, and in Editorial Manager all match. 
This has been amended. 
 
* In the manuscript file, all text should be double-spaced, including Abstract and References. 
This has been amended. 
 
* Reference citations should be in superscript, without parentheses or brackets. Reference citations should 
Response to Reviewers
follow punctuation, such as commas or periods, and preceding semi-colons or colons, with no spaces between 
the citation number and the punctuation mark. 
This has been amended in line with the journal requirements.  
 
* The abstract for your paper exceeds the 250-word limit. Please keep the word count in mind if you are 
required to make any edits on the abstract. If you make any changes to the abstract be sure to update your 
Abstract in Editorial Manager when resubmitting your manuscript. 
The abstract has been amended in line with the 250 word limit and the recommendations from the 
reviewers.  
 
* Please use "sex" not "gender" to refer to male/female. 
This has been amended as requested. 
 
* Please italicize et al. wherever it appears in the paper, including references and tables. 
Amended as requested. 
 
* No commas following e.g. or i.e. 
These have been removed as requested.  
 
* Please use do not abbreviate units of time (e.g. hours not hr or h) - unless referring to a rate. (e.g. 5 min is 
not okay, but 30 rev/min is okay). 
This has been amended as requested 
 
* Images used in figures must have a minimum resolution of 300 dpi. 
This has been amended as requested. 
 
* When you submit your revision, please be sure that your Response to Reviewers is blinded - no author 
names or affiliations in any of the copied comments or responses. No signatures with author names. No 
letterhead. 













The topic is novel and addressing the acute of effects of exoskeleton on vascular health in persons with SCI. 
However, there are major points that need to be addressed prior to final decision. 
1. The authors ignored all the published literature about previous exoskeleton work and did not bother 
acknowledging similar work that has been done in this area. 
Thank you for your comment. We have re-structured the introduction so pertinent exoskeleton research is 
now presented in the second paragraph. The new content in the introduction includes the following: 
‘Robotic-assisted gait training (RGT) is used in the rehabilitation of patients with SCI, and may be a viable 
option to improve functional and health outcomes, and independence, in this population group. Task-specific 
stepping practice enhances the afferent feedback associated with normal locomotion and can induce 
plasticity in the involved motor centers.5,6 Robotic powered exoskeletons are wearable robotic units that 
power a system of motors, pneumatics, levers, or hydraulics to restore locomotion through RGT programs.7,8 
A systematic review and meta-analysis of 14 exoskeleton studies, typically including RGT programs that 
consisted of training sessions three times per week, 60–120 minutes per session, for 1–24 weeks, 
demonstrated that 76% of patients were able to ambulate with no physical assistance on completion of an 
exoskeleton program.8 The physiological demand of such exoskeleton-assisted walking programs are 
comparable to self-reported exertion of an able-bodied person walking at 3 miles per hour, and can elicit 
improvements in spasticity, without any serious adverse events.8,9 Robotic exoskeletons may decrease 
seated time, increase standing and walking time,10,11 thus, potentially ameliorating several of the chronic 
health-related consequences that negatively impact this population.12,13 
 
2. The term ASIA is no longer valid and old term, you need to use AIS or ISNCSCI. 
We have amended the terminology to AIS.  
 
3. Please provide a figure on how this test was conducted in persons with SCI. Please explain the sensitivity of 
this test considering autonomic dysfunction. 
As the measurement of the study outcomes (central and peripheral blood pressure) is very simple, that of a 
blood pressure assessment in a resting supine position, we do not feel a figure is actually necessary. We 
have however included the following information to improve the clarity of the test. It now reads: 
‘At baseline and follow-up assessments, and following 20 minutes undisturbed, supine rest, oscillometric 
pressure waveforms were recorded by a single operator on the left upper arm using a brachial blood 
pressure cuff (SphygmoCor XCEL device, AtCor Medical, Sydney, Australia), in accordance with standard 
manufacturer’s guidelines.24’ 
If the editorial team are adamant that a figure is necessary, we will duly oblige in any future amendments. 
However, a visual presentation of the positioning can be found in reference 25 in the reference list.  
With regards to the ‘sensitivity’ of measuring central BP and AIx measures from the SphygmoCor XCEL, our 
team has shown these measures to be reliable in healthy (Young et al., 2015; Mitchelmore et al., 2018a) and 
clinical non-SCI (stroke) populations (Mitchelmore et al., 2018b) with intra-class correlations > 0.90 typically 
recorded in fasted and non-fasted states. However, no known reliability studies have been reported for 
people with SCI. This could be an area of future research consideration. The manuscript already makes 
reference to the reliability and validity of the device.  
References: 
Young YY, Abdolhosseini P, Brown F, Faulkner J, Lambrick D, Williams MA, Stoner L. (2015). Reliability of 
Oscillometric Central Blood Pressure and Arterial Wave Reflection Readings: Effects of Posture and the Fasted 
State. Journal of Hypertension. 33, 1588-1593. doi: 10.1097/HJH.0000000000000604. 
 
Mitchelmore, A., Stoner, L., Lambrick, D., Jobson, S., Faulkner, J. (2018a). Reliability of oscillometric central 
blood pressure and central systolic loading in individuals over 50 years: effects of posture and fasting, 
Atherosclerosis, 238, 79-85.  
 
Mitchelmore, A., Stoner, L., Lambrick, D., Sykes, L, Eglinton, C, Jobson, S & Faulkner, J. (2018b) ‘Oscillometric 
central blood pressure and central systolic loading in stroke patients: Short-term reproducibility and effects of 
posture and fasting state’, PLoS ONE, 13(11): e0206329. 
 
 
4. The description of the program is rather confusing. Why did you set your program 60 minutes of training in 
the morning and 90 minutes of RGT in the evening. 
This is very impractical who would do 150 minutes per day; 5 days a week; which insurance company or 
coverage will support this? If we want to translate this research findings into real life situation, is this would be 
your recommendation. Please review the current ISCOS guidelines. 
Participants who took part in the study were provided a ‘high-dosage’, intense rehabilitation therapy 
package. This included 60 minutes of conventional physical therapy in the morning, which slightly exceeds 
the minimum recommendations by the National Institute of Clinical Excellence (NICE) guidelines. The RGT 
programme was 90 minutes for logistical reasons. This period of time accounts for up-to 60 minutes of 
Exoskeleton wear time, and 30-minutes to set-up the exoskeleton and to provide ample time to allow 
participants to transfer in and out of the exsoskeleton. This proposed duration is recommended by Ekso 
Bionics trainers when training physical therapists to use the Exoskeleton as a training aid, and is standard 
practice in the rehabilitation center (Hobbs Rehabilitation) whereby this research study was conducted.  
Hobbs rehabilitation offer week long intense therapy packages whereby patients have daily access to 
conventional therapy and RGT. These individuals are either self-funded or supported through UK insurance 
companies. Patients who live further away often use weekly therapy packages for the logistical reasons of 
attending the center. For example, in the present study, patients travelled on average 95 ± 30 km to attend 
the program for those who took part in the RGT group (see Table 1). Daily or weekly travel to the center 
may not be feasible for this group due to the vast distance. As such, the delivery of 150 minutes of therapy 
each day, on five consecutive days, is practical for some individuals with SCI who seek support from physical 
therapists. We have amended the manuscript to improve the clarity of the program. 
With regards to whether we would recommend this type of programme, it is too early to tell. Practically, 
short-duration, intense programmes such as this may be feasible for some individuals living with SCI, but not 
all. It would be of interest for further research to explore the optimal timings, dosages and durations of such 
exoskeleton rehabilitation packages (i.e. how often such a programme should be administered [once a 
month, quarterly etc.), particularly in light of the ISCOS guidelines that recommend that persons with SCI 
engage in at least 20 min of moderate to vigorous intensity aerobic exercise three times per week to 
improve cardiorespiratory fitness (Martin Ginis et al. 2018). We have now made reference to the ISCOS 
guidelines in the discussion. 
Martin Ginis KA, van der Scheer JW, Latimer-Cheung AE, Barrow A, Bourne C, Carruthers P, Bernardi M, Ditor 
DS, Gaudet S, de Groot S, Hayes KC, Hicks AL, Leicht CA, Lexell J, Macaluso S, Manns PJ, McBride CB, Noonan 
VK, Pomerleau P, Rimmer JH, Shaw RB, Smith B, Smith KM, Steeves JD, Tussler D, West CR, Wolfe DL, 
Goosey-Tolfrey VL. Evidence-based scientific exercise guidelines for adults with spinal cord injury: an update 
and a new guideline. Spinal Cord 2018; 56: 308-321 [PMID: 29070812 DOI: 10.1038/s41393-017-0017-3] 
 
5. You need to clearly explain on what mode you have trained your patients and how did you progress your 
training using exoskeleton. 
You mentioned using pro-step plus adaptive mode. Have you adjusted at the level of assistance; in other words 
have all your participants maintained 100% adaptive mode or did you manage to drop the level of assistance 
with training. Considering that you have mixed population of AIS A, B and C? 
 
The mode of the patient was included in the original manuscript. However, further clarity regarding 
‘progressing’ patients during the training can be alluded to. In our study, a reduction in the ‘level’ of motor 
assistance (to support the exoskeleton during the swing phase of the gait cycle) between the first and fifth 
day of the programme was recorded. Due to small sample size for AIS B and C (both n = 1), the following 
interpretation is based on all participants who took part in the RGT program.  
We found that on day 1 and day 5 of the program the maximum assistance of the exoskeleton ranged 
between 98-100%. However, the minimum assistance reduced from 81 ± 1% (day 1) to  67 ± 5% (day 5). 
Reference to this change is now included in the manuscript in both the methods and results section. 
However, the interpretation of these values must be treated with caution as the amount of assistance 
provided by the motor to the exoskeleton can change based on technique/progress etc. as the motor to the 
exoskeleton detects the required/necessary input and alters the required assistance. There could be 
significant variability in this as the motor assistance may vary depending upon the walking speed, under- or 
over- muscular activity, good or poor alignment, cadence, use of mobility aids (walking frame, crutches) etc. 
As a patient progresses over the course of the short-duration, intense RGT program, the increased time 
spent upright/walking may increase fatigue, and as such, could lead to increases in motor assistance. The 
motor assistance is not a key outcome measure for this study due to this variability but data related to it has 
been included in the manuscript.   
 
Reviewer #1: SUMMARY 
Overall, this is nicely written paper which is easy to follow, and which could lead to some important 
technological and clinical advancements for SCI. 
Thank you for your positive overview to the manuscript.  
 
One general comment: 
* Perhaps the title should include "feasibility" or "pilot" 
Reference to a ‘pilot’ study has now been included in the title.  
 
ABSTRACT 
The abstract is a nicely written. A few revisions are worth considering: 
* It would be best to state a primary outcome. It could be stated that central and peripheral hemodynamics 
are measured, but the story would be stronger with a core focused. 
The primary outcome measure has now been included in the abstract as requested.  
 
* How many subjects were randomized to each group? 




Overall, the introduction is clear and flows well. A couple of minor comments: 
 
* Para 2: the first line ends a bit negatively. It seems to suggest this is not a feasible strategy, but I believe the 
authors are arguing opposite? Perhaps here simply state that it's a viable options, as discussion about cost etc 
follows. 
This has been amended as suggested. It now reads.  
‘Robotic-assisted gait training (RGT) is used in the rehabilitation of patients with SCI and may be a viable 
option to improve functional and health outcomes, and independence, in this population group.’ 
 
* Para 2: the second sentence does not transition from the first 
* Last para: is this actually a "pilot" study? 
Reference to the study being a pilot study has now been included. Due to other amendments made to the 
introduction in light of editorial and reviewer comments, we believe that the transition of the second 
sentence is much improved in the revised version. 
 
METHODS 
The methods are well described and easy to read. Just one small comment: 
* What process was used to randomise subjects? Including, was any attempt made to match? 
Due to the pilot nature of the study, a quasi-experimental design was implemented whereby the first 6 
participants were allocated to the RGT group. As stated in the discussion, a fully-randomised controlled trial 
is needed to provide further insight into the effect of RGT on the central vascular health of SCI patients. The 
following has been inserted into the methods section: 
‘Due to the pilot nature of the study, a quasi-experimental design was implemented whereby Pthe first six 
participants were assigned to either athe RGT program, and the remaining six to the  or to a control (Con) 
group.’ 
 
* Were there sample size calculations? Otherwise hence my comment about "pilot study" 
There were no sample size calculations due to the pilot nature to the study. Emphasis on ‘pilot’ has now 
been included in the title and purpose.  
 
RESULTS 
The results are logically stated. To help the reader: 
* Para 1: following the interaction effect, state the magnitude by which each variable decreased (improved) for 
the SGT group. Include a confidence would be useful, e.g., Aix decreased 9% (95%CI: XX, XX) 
We have amended this section of the manuscript as advised by the reviewer. It now reads: 
‘Significant Condition x Time interactions were observed for AIx (η2p = 0.74), AIx75 (η2p = 0.67), AP (η2p = 
0.44), and MAP (η2p = 0.47) (all P < 0.05; Table 2), with cDBP approaching statistical significance (η2p = 
0.35). Each of these outcomes remained constant for Con, but decreased (improved) between baseline and 
follow-up assessments for RGT (Mean [95%CI]; AIx -9% [-12.2 to -5.8]; AIx75 -7% [-9.8 to -4.2]; AP -6% [-13.1 
to -0.7]; MAP -7 mmHg [-10.8 to -2.7]).’ 
 
DISCUSSION 
Some minor comments: 
* Para 1: the statement abut "too expensive" is a little negative. I would consider re-phrasing. 
Thank you for your comment. On reflection, we have removed reference to ‘too expensive’ in this part of 
the manuscript.  
 
* Para 2: not need to report both AIx forms, I would suggest just the former. 
We have removed reference to Aix75 as suggested.  
 
* I would suggest a separate section on implications. This material is somewhat included, but it is buried. i.e., 
how can these findings be used by clinicians, what needs to be done next, what is the feasibility of including 
this device within clinical practice etc. 





Reviewer #2: The authors present findings from a unique study examining the effects of robotic-assisted gait 
training on markers of central vascular health in people with spinal cord injury. Their results demonstrated that 
compared to a control condition, the RGT appeared to have a more favorable central hemodynamic response, 
characterized by a reduction in central MAP, Augmentation pressure and AIx. From a clinical view-point, this is 
important given the prognostic value of these central vascular health markers, in addition support the need to 
further optimize standard rehabilitation and physical treatment in those following SCI. The paper is concise, 
and well-written. The data appear to have been carefully collected. 
Thank you for your positive comments to the manuscript.  
 
I have the following recommendations: 
 
Title: Given the types of measurements performed, the authors could add the word 'central' to vascular health 
("EFFECT OF ROBOTIC-ASSISTED GAIT TRAINING ON THE CENTRAL VASCULAR HEALTH RESPONSE OF 
INDIVIDUALS WITH SPINAL CORD INJURY"). 
The title has been amended as requested.  
 
Did the authors examine the wave-decomposition analysis data to determine the forward and backward 
pressure components and reflection magnitude? These data could provide support of the physiological 
mechanisms discussed. 
This was not possible when the data was collected using our SphygmoCor XCEL as we did not have the 
required software update. We now have the potential to examine the wave decomposition of the 
SphygmoCor XCEL, and this is an area which could be further explored in future SCI, RGT and central 
hemodynamic studies.  
 
 
Reviewer #3: Manuscript #: JSCM-D-19-00062 
Title: Effect of Robot-assisted gait training on the vascular health of 
 
General comments: 
Thank you for the opportunity to read this manuscript. In general, the manuscript is well-written and an 
important addition to the literature. 
Thank you for your positive overview. 
 
Introduction, page 3, line 54 - specify that cost is prohibitive to patients and provide a general estimate of 
costs. 
As there are various different manufacturers of exoskeleton’s and RGT’s we do not feel it pertinent to 
provide an estimate of costs as they can vary between brands.  
 
Page 4 - line 32, re: peripheral blood pressure is a measure as specified in the hypothesis. However the 
preceding paragraph does not support its use, in fact suggesting central BP and AIx. I understand using this 
measure as well. Perhaps you can add rational in the preceding paragraph about why it is helpful to include as 
a measure in addition to the stronger cBP. 
This is a very good point. We have included an additional sentence to support the rationale as to why 
peripheral BP was also recorded in the introduction: 
‘Despite the importance of measuring central BP and AIx, peripheral BP is widely used in clinical and non-
clinical settings as a measure of vascular health.’ 
 
Methods. 
Exclusion criteria needs more detail, starting at line 2 define severely restricted, uncontrolled high levels of 
spasticity, what are significant problems managing BP, etc. In other words, how were these assessed, what are 
the cutoffs. 
Further clarity surrounding inclusion and exclusion criteria has now been embedded into the methods 
(participants) section. This includes: 
‘Participants using the RGT exoskeleton (Ekso bionics, USA) met the manufacturer’s guidelines with regards 
to inclusion criteria for weight (< 100 kg), height (between 1.57 m and 1.93 m), and range of motion 
(bilateral hip flexion 110º, ≤ 12 º knee contracture, neutral dorsiflexion).’ 
‘Participants were excluded if they had uncontrolled high levels of muscle spasticity (Modified Ashworth 
Scale ≥ 4), high blood pressure (> 160/90 mmHg), and/or if there were clinically diagnosed concerns with 
their bone density (e.g. osteoporosis, etc.).’ 
 
Page 5 line 46, include 'All' participants… and perhaps state that All participants were instructed to refrain 
from … (unless there is a clear way that this was tracked/followed-up on later) 
This has been amended as requested. It now reads: 
‘All participants were instructed to refrain from…’ 
 
Line 54 - on each occasion is a bit confusing. Are you referring to On days 1 and 5? Add clarity. 
Thank you for your observation. We have removed ‘on each occasion’ and have changed this section to 
read: 
‘At baseline and follow-up assessments…’ 
 
Page 6, line 21-23 - add justification as to why these measures were selected. Why a difference of 5mmHg? 
Why >4% for AIx? Are these clinically meaningful differences? Standards, etc. Justify. 
The measures reported are considered clinically meaningful changes. They have also been presented as a 
recommended guidance when measuring PWA. This reference was presented in the original submission 
(reference 16).  
 
Control group -- why did the control group get 60 minutes of each session vs. 60/90 as seen in the intervention 
 group? 
When designing the study it was anticipated that the 90 minute RGT session could lead to approximately 60 
minutes of activity (standing upright, walking, sit to stand transitions) due to the time spent setting 
up/adjusting the exoskeleton. Accordingly, we felt the time engaged in activity would be matched between 
the two groups. Both groups would receive 60 minutes of conventional (normal) therapy in the morning and 
a further 60 minutes of therapy in the afternoon (RGT activity or a further bout of conventional therapy).  
 
More information is needed on the home-based exercise session for the reader to fully understand the 
equivalence of the control group. How was it delivered? How was it tracked? 
We have included the following additional information with respect to the daily home-based exercise 
sessions: 
‘This included 30 minutes of static standing using a frame, and 30 minutes of stretches (i.e. hip flexor 
exercises), sitting balance and core-stability exercises for maintenance (e.g. targeting transverse abdominis), 
with relevant rest periods incorporated within this time frame.’ 
 
Line 51, page 7 - AIx75 is introduced as a measure for the first time here. Describe the measures/rationale for 
use. 
An explanation of AIx75 was presented in the PWA section to the methodology. As such, no further 
information will be included.  
 




No mention of Table 1 in the text. No previous mention of what demographics were collected (and how) - 
survey? Patient chart? Combination ? 
Table 1 was mentioned at the end of the first sentence in the participants section to the methods section. 
However, we have amended this section in light of the additional information requested regarding the 
participant demographics. This section now reads:  
‘Participant demographics, including age, height, weight, SCI etiology and type, time since SCI, and distance 
travelled to participate in the research, were collected from a health history questionnaire (Table 1).’ 
 
Add ((n= ) to Tables next to title. 
This has been included as requested. 
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Objective: To investigate the effect of a short-term, robotic-assisted (exoskeleton) gait 
training (RGT) program on central and peripheral hemodynamic measures in patients with 
spinal cord injury (SCI). 
Design: Parallel group, non-randomized trial with before (baseline) and after (follow-up) 
assessments. 
Setting: Single-center, community-based neuro-physiotherapy practice. 
Participants: Twelve individuals with SCI (ASIA classifications A to C). 
Interventions: Participants completed either a 5-day , consecutive, RGT program plus 
physiotherapy (n=6), or a usual care physiotherapy only program (control group; n=6). The 
RGT program consisted of daily 60-minute physiotherapy sessions and, followed by 90-
minutes of gait training in the exoskeletonRGT.  Outcome measures were measured before 
(baseline) and after (follow-up) the rehabilitation program. 
Main Outcome Measure(s): Pulse Wave Analysis was used to assess measures of 
cardiovascular health. The primary outcome measure was arterial wave reflection 
(Augmentation index [AIx]), with  , including supine ccentral and peripheral blood pressures 
also reported. , and arterial wave reflection (Augmentation index [AIx]). Data is presented as 
mean (SD) and effect sizes (partial eta squared; η2p). 
Results: There was a significant reduction in AIx (30±18 to 21±15 %; η2p = 0.75) and mean 
arterial pressure (89±11 to 82±10 mmHg; η2p = 0.47) following completion of the RGT 
program (both P < 0.05). There were no changes in these measures for the control group. 
Although not significantly different, medium to large effects were observed in favor of RGT 
for all other central and peripheral measures (η2p = 0.06 to 0.21), except for heart rate and 
pulse pressure (η2p < 0.04). 
Conclusions: Robotic-assisted gait-trainingRGT using an exoskeleton is a promising therapy 
for improving cardiovascular health in patients with SCI. Specifically, this preliminary short-
term study indicates decreased arterial wave reflection, and supports the need for larger 




































































Trial Registration: Clinical trials Registry (https://clinicaltrials.gov/; Trial Registration 
Number: NCT03611803). 
 




























































































Individuals with spinal cord injury (SCI) have an accelerated trajectory of aging in the 
cardiovascular system compared with same-age individuals in the general 
population,1(1), and accordingly, have a higher rate of cardiovascular mortality.2(2). 
For example, SCI is significantly associated with an increased risk of heart disease 
(odds ratio = 2.72) and stroke (odds ratio = 3.72).3  (3). This is at least partially 
attributed to their impaired blood pressure regulation as a consequence of the 
autonomic nervous system dysfunction, physical inactivity and increased sedentary 
time. As such, there is a pressing need to identify practical strategies for increasing 
physical activity and decreasing sedentary time in people with SCI.4 (4). 
Robotic-assisted gait training (RGT) is used in the rehabilitation of patients 
with SCI, although individual access is often limited and infrequentand may be a 
viable option to improve functional and health outcomes, and independence, in this 
population group. . Task-specific stepping practice enhances the afferent feedback 
associated with normal locomotion and can induce plasticity in the involved motor 
centers.5,6 (5, 6). Robotic powered exoskeletons are wearable robotic units that power 
a system of motors, pneumatics, levers, or hydraulics to restore locomotion through 
RGT programs.7,8 A systematic review and meta-analysis of 14 exoskeleton studies, 
typically including RGT programs that consisted of training sessions three times per 
week, 60–120 minutes per session, for 1–24 weeks, demonstrated that 76% of patients 
were able to ambulate with no physical assistance on completion of an exoskeleton 
program.8 The physiological demand of such exoskeleton-assisted walking programs 
are comparable to self-reported exertion of an able-bodied person walking at 3 miles 




































































events.8,9 Robotic exoskeletons may decrease seated time, increase standing and 
walking time,10,11 thus, potentially ameliorating several of the chronic health-related 
consequences that negatively impact this population.12,13 
As RGT enables practitioners to increase the intensity and total duration of 
physical activity whilst maintaining a physiological gait pattern,14 (7), there may be 
significant benefit for people with SCI to manage their risk of cardiovascular disease 
(CVD). This may be evident if an individual with SCI has regular and continued 
access to such technology. However, there is a paucity of research which has 
considered the vascular benefit of implementing robotic-assisted trainingRGT for 
people with SCI as most research focuses on outcome measures such as gait velocity, 
gait distance, leg strength, balance and spasticity.14 (7). Further, while this technology 
may be practical in terms of application in medical centers and community settings,7, 
the cost is currently prohibitive. Thus, prior to advocating resource intensive 
longitudinal randomized control trials, there i’s a need for short-term trials using 
established measures of cardiovascular health.15 (8). 
 
 The measurement of central hemodynamic parameters, including central 
systolic blood pressure (cSBP) and arterial wave reflection (augmentation index, AIx) 
have the potential to provide clinicians with important diagnostic and prognostic 
information beyond traditional blood pressure (BP) readings.16 (9). Central BP has 
been reported to be a stronger determinant of cardiovascular events than peripheral 
BP,17(10) while AIx, a measure used to infer the degree of systemic arterial wave 
reflection, has been demonstrated to predict future cardiovascular events and all-cause 




































































be obtained using ‘Pulse Wave Analysis’ (PWA), a valid and reliable noninvasive 
procedure.16,19-22 . A recent study demonstrated that individuals with SCI who have 
high cord lesions have more severe cardiovascular autonomic disruption, leading to 
orthostatic BP dysregulation and physical inactivity, which appear to contribute 
independently to increased arterial stiffness in these individuals.23 Despite the 
importance of measuring central BP and AIx, peripheral BP is widely used in clinical 
and non-clinical settings as a measure of vascular health.  
The purpose of this pilot study was to assess the effect of a RGT (exoskeleton) 
program on central and peripheral hemodynamic markers in people with SCI. It was 
hypothesized that improvements in vascular health would be evident through a 
reduction in central and peripheral blood pressureBP, and AIx, in people with SCI 




A convenience sample of 12 individuals with SCI, who were actively seeking neuro-
physiotherapy from a single center (Hobbs Rehabilitation, Winchester, UK), 
participated in the study (Table 1). Participant demographics, including age, height, 
weight, SCI etiology and type, time since SCI, and distance travelled to participate in 
the research study, were collected from a health history questionnaire (Table 1). Due 
to the pilot nature of the study, a quasi-experimental design was implemented 
whereby Pthe first six participants were assigned to either athe RGT program, and the 
remaining six to the  or to a control (Con) group. Participants using the RGT 
exoskeleton (Ekso bionics, USA) met the manufacturer’s guidelines with regards to 




































































range of motion (bilateral hip flexion 110º, ≤ 12 º knee contracture, neutral 
dorsiflexion). . All participants  were standing at least three times a week with 
therapist support and classified, according to the American Spinal Injury Association 
Impairment Scale (ASIA) scale, as either ASIA A (Complete SCI), ASIA B (Sensory 
incomplete SCI), ASIA C (Motor incomplete SCI) or ASIA D (Motor incomplete 
SCI). Participants were excluded if they  hadhad a severely restricted range of motion 
in their lower limbs, uncontrolled high levels of muscle spasticity (Modified 
Ashworth Scale ≥ 4), significant problems managing their blood pressurehigh blood 
pressure (> 160/90 mmHg), and/or if there were clinically diagnosed concerns with 
their bone density (e.g., osteoporosis, etc.). Institutional ethical approval was granted 
and the study was registered with the Clinical trials Registry 
(https://clinicaltrials.gov/; Trial Registration Number: NCT03611803). Written 
informed consent was obtained prior to participation. 
 
Procedures 
The measurement procedures were discussed with all eligible participants prior to the 
start of the study. All participants completed an identical baseline (day 1) and follow-
up (day 5) vascular health assessment using PWA at a neuro-physiotherapy practice, 
between the hours of 11:00 and 12:00 and following a minimum 3-hour fast, at a 
neuro-physiotherapy practice. Between the baseline and follow-up assessments, 
participants in the RGT group attended thea neuro-physiotherapy practice on five 
consecutive days for robotic-assisted gait training using the exoskeleton.  
 




































































All Pparticipants were instructed to refrained from: i) supplement intake during the 
morning of the baseline and follow-up assessments, ii) strenuous rehabilitation 
exercises within 24 hours preceding baseline, and iii) alcohol consumption 24 hours 
prior to both PWA assessment sessions. On each occasionAt baseline and follow-up 
assessments, and following 20 minutes undisturbed, supine rest, oscillometric 
pressure waveforms were recorded by a single operator on the left upper arm using a 
brachial blood pressure cuff (SphygmoCor XCEL device,  (AtCor Medical, Sydney, 
Australia), following in accordance with standard manufacturer’s guidelines.24 (16). 
Each measurement cycle lasted approximately 60 s, consisting of a brachial BP 
recording and then a 10 s subsystolic recording. The merging point (the inflection 
point) of the forward and reflected waves was identical on the derived aortic pressure 
waveform. Augmentation pressure is defined as the maximum systolic pressure minus 
the pressure of the inflection point. The AIx is defined as the augmentation pressure 
expressed as a percentage of central pulse pressure. AIx is influenced by heart rate, 
and thus an index corrected for heart rate at 75 beats per minute (AIx75) was also 
calculated. Two measurements were taken, with a minimum 3 minute interval. If 
blood pressure differed by more than 5 mmHg or AIx by > 4%, a third recording was 




RGT exoskeleton training program 
On completion of the baseline assessment all participants involved in the RGT 
exoskeleton program completed a 60 minute normal conventional therapy session 




































































using a wearable RGT exoskeleton, on five consecutive days. The design of the 
program (conventional therapy in the morning, RGT in the afternoon) was 
standardized for all RGT participants. As demonstrated in Table 1, patients often 
travel long distances to receive therapy from neuro-physiotherapy practices. 
Accordingly, for logistical but also therapeutic reasons, Hobbs Rehabilitation provide 
patients with the opportunity to engage in intense, short-duration therapy programs. 
The 90 minute RGT sessions incorporated the time required to set-up the exoskeleton, 
and all exercise and rest periods. The 60 minute conventional therapy sessions were 
completed by one physiotherapist and included a variety of treatment techniques 
depending on the needs of the patient. This typically included lower limb muscle 
lengthening, core stability and functional sitting balance exercises. 
The 90 minute RGT sessions were completed by two physiotherapists and 
used various settings on the exoskeleton. Patients would commence their program on 
day 1 with the ‘First Step’ setting where the therapist dictated the steps taken. 
Thereafter,Following optimal weight transfer, which was determined by a therapist 
who had > 4 years experience using the exoskeleton, the ‘ProStep+ bilateral adapt’ 
setting was administered.. This setting allows the participant to control their steps by 
transferring their body weight. The therapist would ensure progressive overload by 
altering the following settings to allow the exoskeleton to improve each participant’s 
gait pattern; including degree of leg extension, stride length, step height and step 
speed. A wheeled frame was initially used at the start of the day 1 session, but all 
patients progressed to use crutches by the end of first days session, and were used for 
all remaining RGT training sessions. Participants were allowed rest periods at their 








































































Between baseline and follow-up assessments, participants in the Con group received a 
daily 60 minute conventional physiotherapy session, similar to that undertaken by the 
RGT group, and a daily 60 minute home-based rehabilitation exercise session. This 
included 30 minutes of static standing using a frame, and 30 minutes of stretches (i.e. 
hip flexor exercises), sitting balance and core-stability exercises (e.g. targeting 
transverse abdominis), with relevant rest periods incorporated within this time frame. 
(i.e., sit-to-stand, weight-bearing and core-stability exercises). 
 
 
Statistics   
A series of two-way ANOVAs; Condition (RGT, Con) x Time (Baseline, Follow-up) 
were used to assess changes in PWA (including cSBP, central diastolic blood pressure 
[cDBP], pulse pressure [PP], peripheral systolic blood pressure [SBP], peripheral 
diastolic blood pressure [DBP], mean arterial pressure [MAP], heart rate [HR], AIx 
and AIx75). Data is presented as Mean (SD) with 95% confidence intervals (CI) 
where necessary. Effect sizes are reported to describe the importance of the relevant 
findings in practical terms. Partial eta squared (η2p) was used as a measure of effect 
size, with .0099, .0588 and .1379 representing a small, medium and large effect, 
respectively. (17). Paired sample t-tests were used to assess the participants’ time 
spent upright and walking in the exoskeleton, as well as the number of steps recorded 




































































baseline and follow-up assessmenton completion of the first (day 1) and last day (day 
5) to the RGT program. Cohen’s d was used as a measure of effect size for these 
analyses, with 0.2, 0.5 and 0.8 representing a small, medium and large effect, 
respectively.26 (17). Statistical significance was set at P = .05. All analysis was 
undertaken using SPSS Version 24.0. 
 
Results 
The mean (SD) peripheral and central hemodynamic values can be observed in Table 
2. Significant Condition x Time interactions were observed for AIx (η2p = 0.74), 
AIx75 (η2p = 0.67), AP (η
2
p = 0.44), and MAP (η
2
p = 0.47) (all P < 0.05; Table 2), 
with . cDBP was approaching statistical significance (η2p = 0.35). Each of these 
measures outcomes remained constant for Con, but decreased (improved) between 
baseline and follow-up assessments for RGT (Mean [95%CI]; AIx -9% [-12.2 to -
5.8]; AIx75 -7% [-9.8 to -4.2]; AP -6% [-13.1 to -0.7]; MAP -7 mmHg [-10.8 to -2.7]), 
between baseline and follow-up assessments. There were no interactions for all other 
peripheral and central hemodynamic variables (all P > 0.05) but, with the exception of 
HR and PP, medium to large effect sizes were observed (η2p = 0.06 to 0.21). 
Mean time spent upright by the RGT group in the exoskeleton significantly 
increased from baseline to follow-upday 1 to day 5 (mean [(SD)]: 35 [(14]) vs. 48 
[(13]) min per session; P < 0.05; d = 0.95; Figure 1), as did the amount of time spent 
walking (10 [(3]) vs. 24 [(8] ) min per session; P < 0.05; d = 2.47) and the number of 
steps taken in the exoskeleton (193 [(47]) vs. 523 [(125]) steps per session at baseline 
day 1 and follow-upday 5, respectively; P < 0.01; d = 3.51). The minimum level of 
motor assistance provided by the exoskeleton decreased from 81 (1) % to 67 (5) % 






































































This study demonstrated that five days of consecutive RGT, which elicited an 
increase in time spent upright, walking and stepping whilst wearing the exoskeleton, 
can decrease (improve) arterial wave reflection (AIx) and MAP in individuals with 
SCI. These findings are noteworthy particularly interesting when considering that 
participants only engaged in five RGT training program was of a short 
duration.sessions. Although this form of rehabilitation may prove too expensive for 
continued use, Tthe present study supports the need for further work to determine how 
this approach may be beneficial in a patients’ long-term rehabilitation strategy.  
The mean reduction in AIx and AIx75 of 9% and 7%, respectively, is of 
significant value when considering that AIx has been demonstrated to predict future 
cardiovascular events and all-cause mortality, independent of peripheral or central 
BP.17,18 (10, 11). Vlachopoulos and colleagues17 (10) demonstrated that a 10% 
absolute increase in central AIx is associated with a 32% increase in the risk of 
cardiovascular events and  38% increase in all-cause mortality. Despite our findings, 
the AIx reported at the baseline and follow-up assessments are widely dispersed. 
Accordingly, although the mean reduction in AIx is encouraging from less than one 
week of daily ambulatory robotic training, further research consideration is needed. 
Furthermore, the present study also demonstrated favourable changes to cDBP and 
MAP, with mean decreases of 5 mmHg and 7 mmHg, respectively, observed for the 
RGT group. Although SBP is considered the strongest peripheral BP predictor of 
CVD risk,27,28 (18, 19), in subjects aged 40 years and younger – a population which 
may be at a heightened risk of SCI – DBP has also been shown to be an important 




































































While a full mechanistic explanation is beyond the scope of this article, it may 
be speculated that the changes in peripheral vascular health may lead to a decreased 
central burden. In SCI, central hemodynamic control is impaired due to autonomic 
nervous system dysfunction. This is typically confounded by peripheral vascular 
dysfunction which will increase arterial wave reflection.30 (21). Previous research has 
shown that short-term exercise can improve peripheral vascular health, most likely 
due to an enhanced blood flow-induced shear stress.31 (22). This is a likely reason as 
to why our short-term RGT program could majorly benefit the vascular health of 
people with SCI.  
 
Clinical implications and future considerations 
 Robotic-assisted gait-training programs allow practitioners to increase the 
intensity and total duration of physical activity whilst maintaining a physiological gait 
pattern.14 (7). The present study demonstrated a mean increase in time spent upright 
(13 minutes; 46% increase), walking (14 minutes, 140% increase) and stepping (330 
steps; 170% increase) between baseline and follow-up. These changes, although 
practitioner driven at the start of the training program, are highly encouraging, 
particularly when considering that the mean time spent walking in the exoskeleton (24 
minutes) nearly meets physical activity guidelines for ambulatory counterparts.32 (23). 
Long-term reductions in sedentary time and an increase in physical activity, which 
would help to increase blood flow shear stress,31 (22), could help prevent secondary 
complications associated with CVD for those with SCI.4 (4). When considering the 
prognostic value of central vascular health markers and the observed increases in 
physical activity, the present study demonstrates the importance of administering a 




































































However, as we seek to establish the optimal rehabilitation recommendations for 
individuals with SCI, further research is needed with regards to how and when to 
implement short-term RGT programs into the longer-term rehabilitation strategy in 
people with SCI. It would be valuable to know the optimal training program (length, 
intensity and duration of robotic-assisted gaitRGT training), and over what duration 
changes in arterial wave reflection remain present following such a training program. 
Furthermore, when considering that ISCOS guidelines recommend that persons with 
SCI engage in at least 20 minutes of moderate to vigorous intensity aerobic exercise 
three times per week to improve cardiorespiratory fitness,33 further investigation into 
the cardiometabolic effect of RGT exoskeleton programs is warranted.  It appears that 
such research studies would be applicable and feasible for individuals with SCI as the 
present study has shown that this population group are willing to travel long distances 
for the opportunity to engage in such rehabilitation programs (> 100 km; Table 1). 
RGT programs have also been shown to impact positively on the users lives and may 
enhance their perceived well-being.34(24) Nevertheless, the benefit of the RGT 
exoskeleton program in comparison to more widely available and less costly 
ambulatory assistance physiotherapy training programs needs to be assessed. 
 
 
 Study limitations  
Several limitations should be addressed in order to better contextualize the findings. 
Our preliminary findings are based on only six participants who engaged with the 
short-duration RGT exoskeleton program and who had different ASIA classifications. 
A larger sample size, and the inclusion of a more specific ASIA classification, such as 




































































could make future findings more robust. Although we were able to quantify the time 
spent upright in the RGT group during the exoskeleton sessions, we were unable to 
obtain a similarly objective assessment during the home-based rehabilitation sessions 
for the control group. While it should also be recognized that SCI patients are difficult 
to recruit and require significant resources (therapist time, equipment, etc.), these 
preliminary data support the need for further funding and research. The inclusion of 
additional research centers would be necessary if seeking to recruit a larger study 
population, as our study population was recruited from a single center. When 
considering that our study assesses the acute effect of the proposed study intervention, 
the longitudinal effects on central hemodynamic parameters and arterial wave 
reflection, and the actual delivery of the training program (i.e., frequency of training 
sessions and/or duration of training program), warrants further consideration.  
 
Conclusion  
The aim of this investigation was to determine the effect of a short-term robotic-
assisted (exoskeleton) gait training program on central and peripheral hemodynamic 
variables in people with SCI. Findings suggest that the training program, which 
elicited increases in time spent upright and walking whilst in an exoskeleton, can 
improve established measures of cardiovascular health in individuals with SCI. These 
findings support the need for future research, to examine whether such findings are 
evident in a RCT with a larger sample size, whereby outcome measures are assessed 
in both the short- and longer-term. Such studies may help demonstrate whether 
robotic-assisted training interventions are a practical option for improving 





































































Funding: This research did not receive any specific grant from funding agencies in 
the public, commercial, or not-for-profit sectors. 
 
Conflicts of Interest: None to declare. 
 
References: 
1. Jensen MP, Molton IR, Groah SL, Campbell ML, Charlifue S, Chiodo A, et 
al. Secondary health conditions in individuals aging with SCI: Terminology, concepts 
and analytic approaches. Spinal Cord. 2012;50(5):373-8. 
2. Phillips WT, Kiratli BJ, Sarkarati M, Weraarchakul G, Myers J, Franklin BA, 
et al. Effect of spinal cord injury on the heart and cardiovascular fitness. Current 
Problems in Cardiology. 1998;23(11):641-716. 
3. Cragg JJ, Noonan VK, Krassioukov A, Borisoff J. Cardiovascular disease and 
spinal cord injury: Results from a national population health survey. Neurology. 
2013;81(8):723-8. 
4. Yarar-Fisher C, Heyn P, Zanca JM, Charlifue S, Hsieh J, Brienza DM. Early 
Identification of Cardiovascular Diseases in People With Spinal Cord Injury: Key 
Information for Primary Care Providers. Archives of Physical Medicine and 
Rehabilitation. 2017;98(6):1277-9. 
5. Dobkin BH. Spinal and supraspinal plasticity after incomplete spinal cord 
injury: correlations between functional magnetic resonance imaging and engaged 
locomotor networks. Prog Brain Res. 2000;128:99-111. 
6. Winchester P, McColl R, Querry R. Changes in supraspinal activation patterns 
following robotic locomotor therapy in motor-incomplete spinal cord injury. 




































































7. Gorgey AS, Robotic exoskeletons: The current pros and cons. World J Orthop. 
2018;9:112-19. 
8. Miller LE, Zimmermann AK, Herbert WG. Clinical effectiveness and safety 
of powered exoskeleton-assisted walking in patients with spinal cord injury: 
systematic review with meta-analysis. Med Devices (Auckl). 2016;9:455-66. 
9. Mekki M, Delgado AD, Fry A, Putrino D, Huang V. Robotic rehabilitation 
and spinal cord injury: A narrative review. Neurotherapeutics. 2018;15:604-17.  
10.  Bach Baunsgaard C, Vig Nissen U, Katrin Brust A, Frotzler A, Ribeill C, 
Kalke YB, et al.  Gait training after spinal cord injury: safety, feasibility and gait 
function following 8 weeks of training with the exoskeletons from Ekso Bionics. 
Spinal Cord. 2018;56:106-16. 
11.  Gorgey AS, Wade R, Sumrell R, Villadelgado L, Khalil RE, Lavis T. 
Exoskeleton training may improve level of physical activity after spinal cord injury: A 
case series. Top Spinal Cord Inj Rehabil. 2017;23:245-55. 
12.  Buchholz AC, Martin Ginis KA, Bray SR, Craven BC, Hicks AL, Hayes KC, 
et al. Greater daily leisure time physical activity is associated with lower chronic 
disease risk in adults with spinal cord injury. Appl Physiol Nutr Metab. 2009;34:640-
47.  
13.  Gorgey AS, Dolbow DR, Dolbow JD, Khalil RK, Castillo C, Gater DR. 
Effects of spinal cord injury on body composition and metabolic profile - part I. J 
Spinal Cord Med. 2014;37:693-702  
147. Nam KY, Kim HJ, Kwon BS, Park J-W, Lee HJ, Yoo A. Robot-assisted gait 
training (Lokomat) improves walking function and activity in people with spinal cord 
injury: a systematic review. Journal of NeuroEngineering and Rehabilitation. [journal 




































































158. Stoner L, Credeur D, Dolbow DR, Gater DR. Vascular health toolbox for 
spinal cord injury: Recommendations for clinical practice. Atherosclerosis. 
2015;243(2):373-82. 
169. Young Y, Abdolhosseini P, Brown F, Faulkner J, Lambrick D, Williams MA, 
et al. Reliability of oscillometric central blood pressure and wave reflection readings: 
effects of posture and fasting. Journal of Hypertension. 2015;33(8):1588-93. 
1710. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of Cardiovascular 
Events and All-Cause Mortality With Arterial Stiffness. Journal of the American 
College of Cardiology. 2010;55(13):1318-27. 
1811. Weber T, O’Rourke MF, Lassnig E, Porodko M, Ammer M, Rammer M, et al. 
Pulse waveform characteristics predict cardiovascular events and mortality in patients 
undergoing coronary angiography. J Hypertens. 2010;28:797-805. 
1912. Lowe A, Harrison W, El-Aklouk E, Ruygrok P, Al-Jumaily AM. Noninvasive 
model-based estimation of aortic pulse pressure using suprasystolic brachial pressure 
waveforms. J Biomech. 2009;42:2111-5. 
2013. Hwang MH, Yoo JK, Kim HK, Hwang CL, Mackay K, Hemstreet O, et al. 
Validity and reliability of aortic pulse wave velocity and augmentation index 
determined by the new cuff-based SphygmoCor Xcel. J Hum Hypertension. 
2014;28:475-81. 
2114. Lin AC LA, Sidhu K, Harrison W, Ruygrok P, Stewart R. Evaluation of a 
novel sphygmomanometer, which estimates central aortic blood pressure from 





































































2215. Butlin M QA, Avolio AP. Estimation of central aortic pressure waveform 
features derived from the brachial cuff volume displacement waveform. Conf Proc 
IEEE Eng Med Biol Soc. 2012;2012:2591-4. 
23.  Katzelnick CG, Weir JP, Chiaravalloti ND, Wylie GR, Dyson-Hudson TA, 
Bauman WA, Wecht JM. Impact of blood pressure, lesion level, and physical activity 
on aortic augmentation index in persons with spinal cord injury. J Neurotrauma. 
2017;34:3407-3415.  
 
2416. Stoner L, Lambrick DM, Faulkner J, Young J. Guidelines for the use of pulse 
wave analysis in adults and children. J Atheroscler Thromb. 2013;20:404-6. 
25.  Stoner L, Credeur D, Dolbow DR, Gater DR. Vascular health toolbox for 
spinal cord injury: Recommendations for clinical practice. Atherosclerosis. 
2015;243:e373-e382 
 
2617. Cohen J. A power primer. Psychol Bull. 1992;112:155-9. 
2718. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. 
Blood pressure lowering for prevention of cardiovascular disease and death: a 
systematic review and meta-analysis. The Lancet. 2016;387(10022):957-67. 
2819. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart 
dDisease and Sstroke Sstatistics -—2017 uUpdate: A Rreport Ffrom the American 
Heart Association. Circulation. 2017;135(10):e146-e603. 
290. Perry HM, Miller JP, Baty JD, Carmody SE, Sambhi MP. S. Pretreatment 




































































3021. Stoner L, Sabatier M, VanhHiel L, Groves D, Ripley D, Palardy G, et al. 
Upper vs Lower Extremity Arterial Function After Spinal Cord Injury. The Journal of 
Spinal Cord Medicine. 2006;29(2):138-46. 
3122. Stoner L, Sabatier MJ, Mahoney ET, Dudley GA, McCully KK. Electrical 
stimulation-evoked resistance exercise therapy improves arterial health after chronic 
spinal cord injury. Spinal Cord. 2007;45(1):49-56. 
3223. American College of Sports Medicine. ACSM’s Guidelines for Exercise 
Testing and Prescription. 10th ed. L. Pescatello, R. Arena D, D. Riebe, Thompson P, 
editors. Philadelphia: Lippincott Williams & Wilkins; 2017. 
33.  Martin Ginis KA, van der Scheer JW, Latimer-Cheung AE, Barrow A, Bourne 
C, Carruthers P, et al. Evidence-based scientific exercise guidelines for adults with 
spinal cord injury: an update and a new guideline. Spinal Cord. 2018;56: 308-21. 
3424.  Cahill A, McGinley O, Bertrand C, Lennon O. Gym- based exoskeleton 
walking: A preliminary exploration of non-ambulatory end- user perspectives. 







SphygmoCor XCEL device (AtCor Medical, Sydney, Australia) 






































































Figure 1. Mean (SD) time spent upright and walking in the Exoskeleton at Day 1 and 

























GenderSex Male 3 3 
 






































































30 (13) 38 (17) 
Height (m) a 
 
1.75 (0.09) 1.76 (0.11) 
Weight (kg) a 
 
63.8 (17.4) 62.8 (18.4) 
Etiology Traumatic 6 6 
 
Non-traumatic 0 0 
Type ASIA A 4 2 
 
ASIA B 1 2 
 
ASIA C 1 2 
 
ASIA D 0 0 
Time since SCI (y) a 
 
2.7 (1.3) 3.6 (2.5) 
Distance (km) a* 
 
95 (30) 71 (56) 
 
Abbreviations: ASIA, American Spinal Cord Association Impairment Scale; Con, Control 
group; RGT, Robotic-assisted gait training; SCI, Spinal sord injury 
 
a Mean (standard deviation) 
*This refers to the distance between the participants’ home and the neuro-physiotherapy 


















































































































































Table 2: Mean and SD of PWA indices for individuals with SCI in RGT (n = 6) and Con (n = 6)   1 
  
RGT (n = 6) Con (n = 6) 
  
  
Baseline Follow-up Baseline Follow-up P η2p 
MAP (mmHg) X 89 82 86 87 *0.029 0.47 
 
SD 11 10 17 20 
  SBP (mmHg) X 125 118 130 131 0.157 0.21 
 
SD 19 10 10 11 
  DBP (mmHg) X 71 66 76 76 0.162 0.21 
 
SD 8 8 9 13 
  PP (mmHg) X 55 53 54 55 0.577 0.04 
 
SD 12 3 8 9 
  cSBP (mmHg) X 117 110 118 120 0.135 0.21 
 
SD 17 11 9 9 
  cDBP (mmHg) X 72 67 77 78 0.055 0.35 
 





































































cPP (mmHg) X 51 48 41 42 0.461 0.06 
 
SD 21 19 7 6 
  HR (b·min-1) X 55 56 67 70 0.714 0.02 
 
SD 13 10 16 19 
  AP (%) X 18 12 12 13 *0.050 0.44 
 
SD 16 8 7 6 
  AIx (%) X 30 21 31 33 *0.001 0.75 
 
SD 18 15 12 14 
  AIx75 (%) X 21 14 22 25 *0.002 0.67 
 
SD 18 14 12 13 
   2 
*Significant difference (P < .05) 3 
Abbreviations: AIx, Augmentation index; AP, Augmentation pressure; cDBP, Central diastolic blood pressure; cSBP, Central systolic blood pressure; Con, Control group; 4 
DBP, Diastolic blood pressure;  HR, Heart rate; MAP, mean arterial pressure; PP, Pulse pressure; RGT, Robotic-assisted gait training; SCI, Spinal cord injury; SBP, Systolic 5 









































































































































Effects of robotic-assisted gait training on the central vascular health of 
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Objective: To investigate the effect of a short-term, robotic-assisted (exoskeleton) gait 
training (RGT) program on central and peripheral hemodynamic measures in patients with 
spinal cord injury (SCI). 
Design: Parallel group, non-randomized trial with before (baseline) and after (follow-up) 
assessments. 
Setting: Single-center, community-based neuro-physiotherapy practice. 
Participants: Twelve individuals with SCI (ASI A to C). 
Interventions: Participants completed either a 5-day RGT program plus physiotherapy (n=6), 
or a usual care physiotherapy only program (control group; n=6). The RGT program consisted 
of daily 60-minute physiotherapy and 90-minutes of RGT. Outcome measures were measured 
before and after the rehabilitation program. 
Main Outcome Measure(s): The primary outcome measure was arterial wave reflection 
(Augmentation index [AIx]), with central and peripheral blood pressures also reported. Data 
is presented as mean (SD) and effect sizes (partial eta squared; η2p). 
Results: There was a significant reduction in AIx (30±18 to 21±15 %; η2p=0.75) and mean 
arterial pressure (89±11 to 82±10 mmHg; η2p=0.47) following completion of the RGT 
program (both P<0.05). There were no changes in these measures for the control group. 
Although not significantly different, medium to large effects were observed in favor of RGT 
for all other central and peripheral measures (η2p=0.06 to 0.21), except for heart rate and pulse 
pressure (η2p<0.04). 
Conclusions: RGT using an exoskeleton is a promising therapy for improving cardiovascular 
health in patients with SCI. Specifically, this study indicates decreased arterial wave 
reflection, and supports the need for larger randomized controlled trials. 
Trial Registration: Clinical trials Registry (https://clinicaltrials.gov/; NCT03611803). 
 






































































Individuals with spinal cord injury (SCI) have an accelerated trajectory of aging in the 
cardiovascular system compared with same-age individuals in the general population,1 
and accordingly, have a higher rate of cardiovascular mortality.2 For example, SCI is 
significantly associated with an increased risk of heart disease (odds ratio = 2.72) and 
stroke (odds ratio = 3.72).3 This is at least partially attributed to their impaired blood 
pressure regulation as a consequence of the autonomic nervous system dysfunction, 
physical inactivity and increased sedentary time. As such, there is a pressing need to 
identify practical strategies for increasing physical activity and decreasing sedentary 
time in people with SCI.4 
Robotic-assisted gait training (RGT) is used in the rehabilitation of patients 
with SCI, and may be a viable option to improve functional and health outcomes, and 
independence, in this population group. Task-specific stepping practice enhances the 
afferent feedback associated with normal locomotion and can induce plasticity in the 
involved motor centers.5,6 Robotic powered exoskeletons are wearable robotic units 
that power a system of motors, pneumatics, levers, or hydraulics to restore locomotion 
through RGT programs.7,8 A systematic review and meta-analysis of 14 exoskeleton 
studies, typically including RGT programs that consisted of training sessions three 
times per week, 60–120 minutes per session, for 1–24 weeks, demonstrated that 76% 
of patients were able to ambulate with no physical assistance on completion of an 
exoskeleton program.8 The physiological demand of such exoskeleton-assisted 
walking programs are comparable to self-reported exertion of an able-bodied person 
walking at 3 miles per hour, and can elicit improvements in spasticity, without any 




































































standing and walking time,10,11 thus, potentially ameliorating several of the chronic 
health-related consequences that negatively impact this population.12,13 
As RGT enables practitioners to increase the intensity and total duration of 
physical activity whilst maintaining a physiological gait pattern,14 there may be 
significant benefit for people with SCI to manage their risk of cardiovascular disease 
(CVD). This may be evident if an individual with SCI has regular and continued 
access to such technology. However, there is a paucity of research which has 
considered the vascular benefit of implementing RGT for people with SCI as most 
research focuses on outcome measures such as gait velocity, gait distance, leg strength, 
balance and spasticity.14 Further, while this technology may be practical in terms of 
application in medical centers and community settings,7 the cost is currently 
prohibitive. Thus, prior to advocating resource intensive longitudinal randomized 
control trials, there is a need for short-term trials using established measures of 
cardiovascular health.15 
 The measurement of central hemodynamic parameters, including central 
systolic blood pressure (cSBP) and arterial wave reflection (augmentation index, AIx) 
have the potential to provide clinicians with important diagnostic and prognostic 
information beyond traditional blood pressure (BP) readings.16 Central BP has been 
reported to be a stronger determinant of cardiovascular events than peripheral BP,17 
while AIx, a measure used to infer the degree of systemic arterial wave reflection, has 
been demonstrated to predict future cardiovascular events and all-cause mortality 
independent of peripheral or central BPs.17,18 These parameters can be obtained using 
‘Pulse Wave Analysis’ (PWA), a valid and reliable noninvasive procedure.16,19-22 A 




































































more severe cardiovascular autonomic disruption, leading to orthostatic BP 
dysregulation and physical inactivity, which appear to contribute independently to 
increased arterial stiffness in these individuals.23 Despite the importance of measuring 
central BP and AIx, peripheral BP is widely used in clinical and non-clinical settings 
as a measure of vascular health.  
The purpose of this pilot study was to assess the effect of a RGT (exoskeleton) 
program on central and peripheral hemodynamic markers in people with SCI. It was 
hypothesized that improvements in vascular health would be evident through a 





A convenience sample of 12 individuals with SCI, who were actively seeking neuro-
physiotherapy from a single center (Hobbs Rehabilitation, Winchester, UK), 
participated in the study. Participant demographics, including age, height, weight, SCI 
etiology and type, time since SCI, and distance travelled to participate in the research 
study, were collected from a health history questionnaire (Table 1). Due to the pilot 
nature of the study, a quasi-experimental design was implemented whereby the first 
six participants were assigned to the RGT program, and the remaining six to the 
control (Con) group. Participants using the RGT exoskeleton (Ekso bionics, USA) 
met the manufacturer’s guidelines with regards to inclusion criteria for weight (< 100 
kg), height (between 1.57 m and 1.93 m), and range of motion (bilateral hip flexion 
110º, ≤ 12 º knee contracture, neutral dorsiflexion). All participants  were standing at 




































































American Spinal Injury Association Impairment Scale (ASI) scale, as either ASI A 
(Complete SCI), ASI B (Sensory incomplete SCI), ASI C (Motor incomplete SCI) or 
ASI D (Motor incomplete SCI). Participants were excluded if they had uncontrolled 
high levels of muscle spasticity (Modified Ashworth Scale ≥ 4), high blood pressure 
(> 160/90 mmHg), and/or if there were clinically diagnosed concerns with their bone 
density (e.g. osteoporosis, etc.). Institutional ethical approval was granted and the 
study was registered with the Clinical trials Registry (https://clinicaltrials.gov/; Trial 




The measurement procedures were discussed with all eligible participants prior to the 
start of the study. All participants completed an identical baseline (day 1) and follow-
up (day 5) vascular health assessment using PWA at a neuro-physiotherapy practice, 
between the hours of 11:00 and 12:00 and following a minimum 3-hour fast. Between 
the baseline and follow-up assessments, participants in the RGT group attended the 
neuro-physiotherapy practice on five consecutive days for robotic-assisted gait 
training using the exoskeleton.  
 
Pulse Wave Analysis  
All participants were instructed to refrain from: i) supplement intake during the 
morning of the baseline and follow-up assessments, ii) strenuous rehabilitation 
exercises within 24 hours preceding baseline, and iii) alcohol consumption 24 hours 
prior to both PWA assessment sessions. At baseline and follow-up assessments, and 




































































recorded by a single operator on the left upper arm using a brachial blood pressure 
cuff (SphygmoCor XCEL device, AtCor Medical, Sydney, Australia), in accordance 
with standard manufacturer’s guidelines.24 Each measurement cycle lasted 
approximately 60 s, consisting of a brachial BP recording and then a 10 s subsystolic 
recording. The merging point (the inflection point) of the forward and reflected waves 
was identical on the derived aortic pressure waveform. Augmentation pressure is 
defined as the maximum systolic pressure minus the pressure of the inflection point. 
The AIx is defined as the augmentation pressure expressed as a percentage of central 
pulse pressure. AIx is influenced by heart rate, and thus an index corrected for heart 
rate at 75 beats per minute (AIx75) was also calculated. Two measurements were 
taken, with a minimum 3 minute interval. If blood pressure differed by more than 5 
mmHg or AIx by > 4%, a third recording was taken and the closest two recordings 
were averaged in line with recommendations.24,25 
 
RGT exoskeleton training program 
On completion of the baseline assessment all participants involved in the RGT 
exoskeleton program completed a 60 minute conventional therapy session (morning) 
and a 90 minute RGT session (afternoon) using a wearable exoskeleton, on five 
consecutive days. The design of the program (conventional therapy in the morning, 
RGT in the afternoon) was standardized for all RGT participants. As demonstrated in 
Table 1, patients often travel long distances to receive therapy from neuro-
physiotherapy practices. Accordingly, for logistical but also therapeutic reasons, 
Hobbs Rehabilitation provide patients with the opportunity to engage in intense, 
short-duration therapy programs. The 90 minute RGT sessions incorporated the time 




































































conventional therapy sessions were completed by one physiotherapist and included a 
variety of treatment techniques depending on the needs of the patient. This typically 
included lower limb muscle lengthening, core stability and functional sitting balance 
exercises. 
The 90 minute RGT sessions were completed by two physiotherapists and 
used various settings on the exoskeleton. Patients would commence their program on 
day 1 with the ‘First Step’ setting where the therapist dictated the steps taken. 
Following optimal weight transfer, which was determined by a therapist who had > 4 
years experience using the exoskeleton, the ‘ProStep+ bilateral adapt’ setting was 
administered. This setting allows the participant to control their steps by transferring 
their body weight. The therapist would ensure progressive overload by altering the 
following settings to allow the exoskeleton to improve each participant’s gait pattern; 
including degree of leg extension, stride length, step height and step speed. A wheeled 
frame was initially used at the start of the day 1 session, but all patients progressed to 
use crutches by the end of first days session, and were used for all remaining RGT 
training sessions. Participants were allowed rest periods at their request. The 
participants ‘Up Time’, ‘Walk Time’ and number of ‘Steps’ per session were 




Between baseline and follow-up assessments, participants in the Con group received a 
daily 60 minute conventional physiotherapy session, similar to that undertaken by the 
RGT group, and a daily 60 minute home-based rehabilitation exercise session. This 




































































hip flexor exercises), sitting balance and core-stability exercises (e.g. targeting 
transverse abdominis), with relevant rest periods incorporated within this time frame.  
 
Statistics   
A series of two-way ANOVAs; Condition (RGT, Con) x Time (Baseline, Follow-up) 
were used to assess changes in PWA (including cSBP, central diastolic blood pressure 
[cDBP], pulse pressure [PP], peripheral systolic blood pressure [SBP], peripheral 
diastolic blood pressure [DBP], mean arterial pressure [MAP], heart rate [HR], AIx 
and AIx75). Data is presented as Mean (SD) with 95% confidence intervals (CI) 
where necessary. Effect sizes are reported to describe the importance of the relevant 
findings in practical terms. Partial eta squared (η2p) was used as a measure of effect 
size, with .0099, .0588 and .1379 representing a small, medium and large effect, 
respectively. Paired sample t-tests were used to assess the participants’ time spent 
upright and walking in the exoskeleton, the number of steps recorded and the 
minimum amount of motor assistance provided by the exoskeleton on completion of 
the first (day 1) and last day (day 5) to the RGT program. Cohen’s d was used as a 
measure of effect size for these analyses, with 0.2, 0.5 and 0.8 representing a small, 
medium and large effect, respectively.26 Statistical significance was set at P = .05. All 
analysis was undertaken using SPSS Version 24.0. 
 
Results 
The mean (SD) peripheral and central hemodynamic values can be observed in Table 
2. Significant Condition x Time interactions were observed for AIx (η2p = 0.74), 
AIx75 (η2p = 0.67), AP (η
2
p = 0.44), and MAP (η
2
p = 0.47) (all P < 0.05), with cDBP 




































































constant for Con, but decreased (improved) between baseline and follow-up 
assessments for RGT (Mean [95%CI]; AIx -9% [-12.2 to -5.8]; AIx75 -7% [-9.8 to -
4.2]; AP -6% [-13.1 to -0.7]; MAP -7 mmHg [-10.8 to -2.7]). There were no 
interactions for all other peripheral and central hemodynamic variables (all P > 0.05) 
but, with the exception of HR and PP, medium to large effect sizes were observed (η2p 
= 0.06 to 0.21). 
Mean time spent upright by the RGT group in the exoskeleton significantly 
increased from day 1 to day 5 (mean [SD]: 35 [14] vs. 48 [13] min per session; P < 
0.05; d = 0.95; Figure 1), as did the amount of time spent walking (10 [3] vs. 24 [8] 
min per session; P < 0.05; d = 2.47) and the number of steps taken in the exoskeleton 
(193 [47] vs. 523 [125] steps per session at day 1 and day 5, respectively; P < 0.01; d 
= 3.51). The minimum level of motor assistance provided by the exoskeleton 




This study demonstrated that five days of consecutive RGT, which elicited an 
increase in time spent upright, walking and stepping whilst wearing the exoskeleton, 
can decrease (improve) arterial wave reflection (AIx) and MAP in individuals with 
SCI. These findings are particularly interesting when considering that RGT training 
program was of a short duration. The present study supports the need for further work 
to determine how this approach may be beneficial in a patients’ long-term 
rehabilitation strategy.  
The mean reduction in AIx of 9% is of significant value when considering that 




































































mortality, independent of peripheral or central BP.17,18 Vlachopoulos and colleagues17 
demonstrated that a 10% absolute increase in central AIx is associated with a 32% 
increase in the risk of cardiovascular events and  38% increase in all-cause mortality. 
Despite our findings, the AIx reported at the baseline and follow-up assessments are 
widely dispersed. Accordingly, although the mean reduction in AIx is encouraging 
from less than one week of daily ambulatory robotic training, further research 
consideration is needed. Furthermore, the present study also demonstrated favourable 
changes to cDBP and MAP, with mean decreases of 5 mmHg and 7 mmHg, 
respectively, observed for the RGT group. Although SBP is considered the strongest 
peripheral BP predictor of CVD risk,27,28 in subjects aged 40 years and younger – a 
population which may be at a heightened risk of SCI – DBP has also been shown to 
be an important predictor of CVD risk.29  
While a full mechanistic explanation is beyond the scope of this article, it may 
be speculated that the changes in peripheral vascular health may lead to a decreased 
central burden. In SCI, central hemodynamic control is impaired due to autonomic 
nervous system dysfunction. This is typically confounded by peripheral vascular 
dysfunction which will increase arterial wave reflection.30 Previous research has 
shown that short-term exercise can improve peripheral vascular health, most likely 
due to an enhanced blood flow-induced shear stress.31 This is a likely reason as to 
why our short-term RGT program could majorly benefit the vascular health of people 
with SCI.  
 
Clinical implications and future considerations 
 Robotic-assisted gait-training programs allow practitioners to increase the 




































































pattern.14 The present study demonstrated a mean increase in time spent upright (13 
minutes; 46% increase), walking (14 minutes, 140% increase) and stepping (330 
steps; 170% increase) between baseline and follow-up. These changes, although 
practitioner driven at the start of the training program, are highly encouraging, 
particularly when considering that the mean time spent walking in the exoskeleton (24 
minutes) nearly meets physical activity guidelines for ambulatory counterparts.32 
Long-term reductions in sedentary time and an increase in physical activity, which 
would help to increase blood flow shear stress,31 could help prevent secondary 
complications associated with CVD for those with SCI.4 When considering the 
prognostic value of central vascular health markers and the observed increases in 
physical activity, the present study demonstrates the importance of administering a 
short-duration, intense exoskeleton training program for people living with SCI. 
However, as we seek to establish the optimal rehabilitation recommendations for 
individuals with SCI, further research is needed with regards to how and when to 
implement short-term RGT programs into the longer-term rehabilitation strategy. It 
would be valuable to know the optimal training program (length, intensity and 
duration of RGT), and over what duration changes in arterial wave reflection remain 
present following such a training program. Furthermore, when considering that 
ISCOS guidelines recommend that persons with SCI engage in at least 20 minutes of 
moderate to vigorous intensity aerobic exercise three times per week to improve 
cardiorespiratory fitness,33 further investigation into the cardiometabolic effect of 
RGT exoskeleton programs is warranted.  It appears that such research studies would 
be applicable and feasible for individuals with SCI as the present study has shown that 
this population group are willing to travel long distances for the opportunity to engage 




































































shown to impact positively on the users lives and may enhance their perceived well-
being.34 Nevertheless, the benefit of the RGT exoskeleton program in comparison to 
more widely available and less costly ambulatory assistance physiotherapy training 
programs needs to be assessed. 
 
Study limitations  
Several limitations should be addressed in order to better contextualize the findings. 
Our preliminary findings are based on only six participants who engaged with the 
short-duration RGT exoskeleton program and who had different ASI classifications. 
A larger sample size, and the inclusion of a more specific ASI classification, such as 
the recruitment of individuals with only ASI ‘A’ or ‘B’ on the impairment scale, 
could make future findings more robust. Although we were able to quantify the time 
spent upright in the RGT group during the exoskeleton sessions, we were unable to 
obtain a similarly objective assessment during the home-based rehabilitation sessions 
for the control group. While it should also be recognized that SCI patients are difficult 
to recruit and require significant resources (therapist time, equipment, etc.), these 
preliminary data support the need for further funding and research. The inclusion of 
additional research centers would be necessary if seeking to recruit a larger study 
population, as our study population was recruited from a single center. When 
considering that our study assesses the acute effect of the proposed study intervention, 
the longitudinal effects on central hemodynamic parameters and arterial wave 
reflection, and the actual delivery of the training program (i.e. frequency of training 






































































The aim of this investigation was to determine the effect of a short-term robotic-
assisted (exoskeleton) gait training program on central and peripheral hemodynamic 
variables in people with SCI. Findings suggest that the training program, which 
elicited increases in time spent upright and walking whilst in an exoskeleton, can 
improve established measures of cardiovascular health in individuals with SCI. These 
findings support the need for future research, to examine whether such findings are 
evident in a RCT with a larger sample size, whereby outcome measures are assessed 
in both the short- and longer-term. Such studies may help demonstrate whether 
robotic-assisted training interventions are a practical option for improving 
cardiovascular health outcomes, morbidity and mortality in individuals with SCI.  
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SphygmoCor XCEL device (AtCor Medical, Sydney, Australia) 
Exoskeleton (Ekso bionics, USA) 
 
Figure Legend 
Figure 1. Mean (SD) time spent upright and walking in the Exoskeleton at Day 1 and 




























































































Sex Male 3 3 
 
Female 3 3 
Age (y)a 
 
30 (13) 38 (17) 
Height (m) a 
 
1.75 (0.09) 1.76 (0.11) 
Weight (kg) a 
 
63.8 (17.4) 62.8 (18.4) 
Etiology Traumatic 6 6 
 
Non-traumatic 0 0 
Type ASI A 4 2 
 
ASI B 1 2 
 
ASI C 1 2 
 
ASI D 0 0 
Time since SCI (y) a 
 
2.7 (1.3) 3.6 (2.5) 
Distance (km) a* 
 
95 (30) 71 (56) 
 
Abbreviations: ASI, American Spinal Cord Association Impairment Scale; Con, Control 
group; RGT, Robotic-assisted gait training; SCI, Spinal sord injury 
 
a Mean (standard deviation) 
*This refers to the distance between the participants’ home and the neuro-physiotherapy 








































































Table 2: Mean and SD of PWA indices for individuals with SCI in RGT (n = 6) and Con (n = 6)  1 
  
RGT (n = 6) Con (n = 6) 
  
  
Baseline Follow-up Baseline Follow-up P η2p 
MAP (mmHg) X 89 82 86 87 *0.029 0.47 
 
SD 11 10 17 20 
  SBP (mmHg) X 125 118 130 131 0.157 0.21 
 
SD 19 10 10 11 
  DBP (mmHg) X 71 66 76 76 0.162 0.21 
 
SD 8 8 9 13 
  PP (mmHg) X 55 53 54 55 0.577 0.04 
 
SD 12 3 8 9 
  cSBP (mmHg) X 117 110 118 120 0.135 0.21 
 
SD 17 11 9 9 
  cDBP (mmHg) X 72 67 77 78 0.055 0.35 
 





































































cPP (mmHg) X 51 48 41 42 0.461 0.06 
 
SD 21 19 7 6 
  HR (b·min-1) X 55 56 67 70 0.714 0.02 
 
SD 13 10 16 19 
  AP (%) X 18 12 12 13 *0.050 0.44 
 
SD 16 8 7 6 
  AIx (%) X 30 21 31 33 *0.001 0.75 
 
SD 18 15 12 14 
  AIx75 (%) X 21 14 22 25 *0.002 0.67 
 
SD 18 14 12 13 
   2 
*Significant difference (P < .05) 3 
Abbreviations: AIx, Augmentation index; AP, Augmentation pressure; cDBP, Central diastolic blood pressure; cSBP, Central systolic blood pressure; Con, Control group; 4 
DBP, Diastolic blood pressure;  HR, Heart rate; MAP, mean arterial pressure; PP, Pulse pressure; RGT, Robotic-assisted gait training; SCI, Spinal cord injury; SBP, Systolic 5 
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